PDCD1 and neoplasm: Particularly, highly immunogenic tumors susceptible to immunotherapy like melanoma, microsatellite instable colorectal cancer, or triple-negative breast cancer carry PD-1+/LAG-3+ CD8+ tumor-infiltrating T cells [8].